Is Theravance Biopharma, Inc. technically bullish or bearish?

Nov 04 2025 11:35 AM IST
share
Share Via
As of October 31, 2025, Theravance Biopharma, Inc. shows a bullish trend supported by positive MACD and Bollinger Bands, despite mixed signals from the RSI and KST, and has significantly outperformed the S&P 500 with an 84.71% return over the past year.
As of 31 October 2025, the technical trend for Theravance Biopharma, Inc. has changed from mildly bullish to bullish. The current stance is bullish, supported by bullish signals in both the weekly and monthly MACD, as well as bullish Bollinger Bands across the same time frames. The daily moving averages also indicate a bullish trend. However, the monthly RSI shows a bearish signal, and the KST is mildly bearish on the weekly but bullish on the monthly, which suggests some mixed signals.

In terms of performance, the stock has outperformed the S&P 500 significantly over the past year, returning 84.71% compared to the S&P 500's 19.89%. Over the year-to-date period, the stock has returned 61.74% versus the S&P 500's 16.30%.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News